EAEunice Ampem-Danso

Eunice Ampem-Danso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eunice Ampem-Danso has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Justice Kumi

    Department of Clinical Pathology, Noguchi Memorial Institute for Medical Research, College of Health Sciences University of Ghana Accra Ghana

    4 shared publications
  • Sherif Hamidu

    Department of Clinical Pathology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana, ug.edu.gh

    4 shared publications
  • Abigail Aning

    Department of Clinical Pathology, Noguchi Memorial Institute for Medical Research, College of Health Sciences University of Ghana Accra Ghana

    2 shared publications
  • Fatima Hamidu

    Faculty of Medicine International University of Africa Khartoum Sudan

    2 shared publications
  • Mustapha Abdul Mumin Mohammed

    Department of Internal Medicine Central Hospital of Biel Biel Switzerland

    2 shared publications
  • Seth Kwabena Amponsah

    Department of Biomedical Sciences, School of Basic and Biomedical Sciences, University of Health and Allied Sciences

    2 shared publications

Latest Publications

  • Open Access

    Natural Products as Geroprotective Modulators in Diabetic Nephropathy: A Mechanistic Framework Integrating Aging Hallmarks and the AMPK–SIRT1–Nrf2 Axis

    by Sherif Hamidu, Latif Adams, Eunice Ampem‐Danso, Justice Kumi, Abigail Aning, Fatima Hamidu, Mustapha Abdul Mumin Mohammed, Ayuba Nii Darku Ankrah, Seth Kwabena Amponsah

    Diabetic nephropathy (DN) is not merely a metabolic complication, it is an age‐accelerated kidney disorder in which biological aging pathways amplify hyperglycemic injury. Mounting evidence implicates cellular senescence, mitochondrial dysfunction, chronic inflammation (“inflammaging”), and epigenetic drift as central drivers of DN progression. However, current therapies fail to address these aging mechanisms. This review introduces a geroscience‐based framework in which natural products are conceptualized as geroprotective modulators capable of reprogramming age‐related molecular damage in the diabetic kidney. We integrate preclinical evidence showing that compounds such as resveratrol, quercetin, curcumin, ginsenosides, and berberine restore the AMPK–SIRT1–Nrf2 regulatory triad, thereby rejuvenating mitochondrial bioenergetics, suppressing inflammasome activation, and mitigating fibrosis. A new mechanistic classification model is proposed, categorizing natural products by the specific hallmarks of aging they target; cellular senescence, mitochondrial decline, inflammaging, and epigenetic alterations rather than by chemical class. Finally, we advance a unifying hypothesis: simultaneous activation of the AMPK–SIRT1–Nrf2 axis represents the central mechanism through which diverse natural products confer renoprotection and longevity signaling in DN. By linking geroscience to phytotherapy, this review provides a novel conceptual and mechanistic roadmap for developing multi‐targeted interventions to slow kidney aging and improve outcomes in diabetic patients.


  • Open Access

    Evaluation of Antimicrobial Activity of Aloe vera Gel Extract on Hospital‐Acquired Methicillin‐Resistant Staphylococcus aureus

    by Jones Gyamerah, Justice Kumi, Eric N. Y. Nyarko, Janet Ampofo, Sherif Hamidu, Eunice E. Ampem-Danso, Vida Yirenkyiwaa Adjei, Felicia Owusu

    Introduction: Aloe vera has a long history as a medicinal plant with numerous therapeutic uses. Methicillin‐resistant Staphylococcus aureus (MRSA) is a type of bacteria resistant to commonly used antibiotics such as penicillin. Hospital‐acquired methicillin‐resistant Staphylococcus aureus (Ha‐MRSA) refers to MRSA infections that arise in healthcare settings, usually 48 h or longer after hospital admission or in individuals with recent hospitalization. This research is aimed at investigating the effectiveness of Aloe vera gel extract against Ha‐MRSA. Methods: The agar well boring diffusion and the broth dilution test methods were employed, respectively, to assess the susceptibility of Ha‐MRSA to Aloe vera gel extract in ethanol and DMSO medium. These extraction media were compared for their effectiveness as the solvent of extraction for the susceptibility test. Results: A minimum inhibitory concentration of 0.2 mg/L of Aloe vera gel extract in the ethanolic extraction medium was achieved, indicating susceptibility of the Ha‐MRSA strain as recommended by EUCAST/ESCMID. Conclusion: Aloe vera gel ethanol extract was sensitive against Ha‐MRSA strains but was resistant in the DMSO extraction method. It is recommended that further research be carried out to ascertain the bioactive compounds responsible for antimicrobial activity.


  • Open Access

    Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products

    by Sherif Hamidu, Seth Kwabena Amponsah, Abigail Aning, Latif Adams, Justice Kumi, Eunice Ampem-Danso, Fatima Hamidu, Mustapha Abdul Mumin Mohammed, Gabriel Tettey Ador, Sanjida Khatun

    Aging is a multifactorial process driven by accumulating cellular damage. Ferroptosis—an iron‐dependent, lipid peroxidation‐mediated form of cell death—has emerged as a critical contributor to age‐related tissue degeneration. This review synthesizes current evidence linking ferroptosis to key aging hallmarks, including oxidative stress, chronic inflammation, mitochondrial dysfunction, and dysregulated iron metabolism. Central to these interactions is the age‐associated decline in antioxidant defenses (e.g., glutathione, glutathione peroxidase 4 [GPx4]) and paradoxical iron dynamics, where systemic deficiency coexists with intracellular overload, promoting reactive oxygen species (ROS) generation via the Fenton reaction. Natural products such as resveratrol, curcumin, and epigallocatechin gallate (EGCG) exhibit promising anti‐ferroptotic effects through mechanisms including iron chelation, ROS scavenging, and upregulation of endogenous antioxidants. Preclinical and clinical studies indicate their potential in reducing lipid peroxidation and enhancing cellular resilience in aging contexts. However, challenges such as poor bioavailability and tissue‐specific iron dysregulation remain. This review explores how combinatorial approaches—targeting multiple ferroptosis pathways—may offer synergistic therapeutic benefits. Collectively, ferroptosis inhibition emerges as a promising strategy to mitigate age‐associated tissue damage and promote healthy aging.


  • Open Access

    Point-of-care circulating cathodic antigen positivity and associated factors in school children one year after mass praziquantel administration in an endemic district in Ghana

    by Isaac Tukwarlba, Enoch Aninagyei, Puopelle Dakorah Mavis, Juliana Attoh, Kwabena Obeng Duedu, Justice Kumi, Eunice Ampem-Danso, Desmond Omane Acheampong

  • Open Access

    Anticancer and Antioxidant Properties of Vernonia amygdalina Delile and Citrus aurantifolia (Christm.) Swingle Juice Extracts: An In Vitro Study

    by Eunice E. Ampem Danso, Eunice Dotse, Abigail Aning, Trudy Philips, Sherif Hamidu, Janet Ampofo

    Introduction:Vernonia amygdalina Delile (VAD), also known as bitter leaf, is widely utilized in traditional medicine for the treatment of various ailments, including cancer. The presence of bioactive compounds in VAD is believed to be responsible for its characteristic bitterness. In Ghana, it is a common practice to mitigate the bitterness of VAD by combining it with Citrus aurantifolia (Christm.) Swingle (lime) juice extracts, although this method lacks scientific evidence and documentation. Therefore, the antioxidant and anticancer activities of VAD and lime juice extracts (V5) and their combined effects were evaluated in vitro.Method: The antioxidant activity and cytotoxic effects of VAD extracts were determined against Jurkat, MCF‐7, HepG2, and PNT2 cells using the 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) assay to quantify antioxidant activity and the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay to assess cytotoxicity. The statistical analysis of the data was conducted using Microsoft Excel and GraphPad Prism 8.0. Linear regression was employed to determine the correlation between the concentration and the percentage of antioxidant activity, while p values were calculated using Student’s t‐test.Results: The laboratory analysis focused on the extracts V1, V2, V3, V4, and V5. Briefly, V1 and V2 contained equal amounts of saponins and terpenoids. Among these, V2 exhibited the highest free radical scavenging activity, as indicated by an EC50 value of 2.14 ± 0.06 mg/mL. V2 also demonstrated cytotoxicity against the MCF‐7, HepG2, Jurkat, and PNT2 cell lines. On the other hand, V3 and V4 did not show any cytotoxic effects across all tested cell lines. In contrast, V5 was toxic to HepG2 and MCF‐7 cells but had no cytotoxic effect on Jurkat cell lines. V2 exhibited dose‐dependent cytotoxicity (0–1000 μg/mL), with the strongest inhibition observed against Jurkat cells (IC50 value = 96.341 μg/mL) and a selective index of 3.567. The difference in activity between the extracts from different parts of the plant and the extract combined with lime juice was significant (p < 0.05), indicating a synergistic effect of the phytochemicals in both VAD and lime juice.Conclusion: V2 and V5 demonstrated a remarkable antioxidant property, and they are effective in inhibiting cancer cell lines, respectively.